english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2024 Recap > Drug shortages: Prescrire calls for transparency (July 2024)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2024
Drug shortages: Prescrire calls for transparency (July 2024)

In October 2023, ahead of the publication of a Communication from the European Commission on addressing medicine shortages in the European Union (EU), a joint letter was sent to the Commission by Prescrire, the European Public Health Alliance (EPHA) and the patient rights umbrella organisation France Assos Santé (1,2).

The Commission is in favour of introducing a "Voluntary Solidarity Mechanism" across EU member states to address drug shortages. The cosignatories of the letter emphasised that transparency about drug stocks will be needed if such a mechanism is to work. They urged the Commission to call for the introduction of requirements for manufacturers and wholesalers that provide information on stock levels to the EU's national drug regulatory agencies.

References
1- European Commission "Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions": 19 pages. 2- EPHA-FAS-Prescrire "Joint letter" 17 October 2023: 1 page.
 

©Prescrire 1 July 2024

Source: "Drug shortages: Prescrire calls for transparency" Prescrire Int 2024; 33 (261): 195. Free.

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on Facebook Share on Twitter